FIND-CKD Extends Finerenone's Benefit to Non-Diabetic CKD

In a special episode of Kidney Compass, Shikha Wadhwani, MD, MS, puts her regular co-host, Brendan Neuen, MBBS, PhD, in the "hot seat," asking him about results from FIND-CKD, the phase 3 trial showing finerenone slows eGFR decline and cuts cardiorenal risk by 23% in non-diabetic chronic kidney disease (CKD) over 32 months of follow-up, including the prespecified glomerulonephritis (GN) subgroup analysis he presented at the European Renal Association (ERA) Congress in June.

For more: https://www.hcplive.com/view/kidney-compass-find-ckd-extends-finerenone-s-benefit-to-non-diabetic-ckd